The current standard Drp1 GTPase inhibitor, Mdivi-1, obviously inhibits fissogenic activity, resulting in the reduction of cell proliferation and tumor growth and the promotion of cell apoptosis in multiple cancer cells [32]. The gene discussed is DNM1L; the disease is neoplasm.